To become one of the pre-eminent spine companies in the world by developing products that promote healing in patients with spinal disorders.

At Globus, achieving pre-eminence is not a self-proclaimed title and it' s not about the attainment of financial milestones. Rather, it begins and ends with creating products that help people get better: to lead more active, productive, pain free lives as the result of successful spine surgery.

Globus intends to achieve pre-eminence through a combination of thorough research and testing; extensive surgeon collaboration in product development; precise manufacturing of high quality products; effective peer-to-peer education and excellence in service and support. We believe that by focusing our efforts in these areas, surgeons will achieve the clinical outcomes that will ultimately cause them to consider Globus one of the pre-eminent spine companies in the world.

Medical Vision

• Motion preservation will become the gold standard of treatment for most degenerative spine conditions, resulting in more predictable outcomes, better quality of life and reduced iatrogenic degeneration.
  
  
• Fusion will remain the optimum treatment for patients with advanced degeneration, trauma, scoliosis and spondylolisthesis.

Clinical & Scientific Vision

• Both columns of the spine have to be considered in restoring normal kinematics
• All fusion and motion preservation systems must:
  • Restore disc height and lordosis
  • Provide adequate decompression
  • Utilize existing and familiar surgical techniques and approaches

Market Vision

• Be the leader in motion preservation technologies.
• Provide motion preservation options for procedures, approaches and techniques that are commonly used today.
• Employ continuous, iterative innovation with our fusion portfolio with an ever increasing focus on biomaterials and minimally invasive solutions.